Human papillomavirus (HPV)
We strengthen antiviral immunity in human papillomavirus (HPV) infection.
About the disease
Human papillomavirus (HPV) infection can persist in the body for years if immunity does not cope with the virus. Some types of the virus cause only skin manifestations, but some are linked to a risk of cancer complications, including cervical cancer. That is why it is important to help the body bring the virus under control.
We mobilize the body's own antiviral immunity to strengthen control over the infection. The goal is to help the body restrain the virus and reduce its activity.
The method is relevant in persistent infection, when the virus does not clear for a long time, and in recurrent manifestations. It is considered as part of an overall monitoring plan together with a gynecologist or urologist.
Immunotherapy is combined with other treatment methods and regular monitoring. It does not cancel the screening and follow-up that are important in HPV, especially in women.
The physician decides whether it is possible and how it is structured after assessing the type of virus, the duration of infection, and examination results. The program is selected individually.
Antiviral immunity
The method mobilizes the body's own defense against the virus.
Control of persistent infection
Helps when the virus does not clear for a long time.
Attention to cancer risks
Some HPV types are linked to a risk of complications, including cervical cancer.
Does not cancel screening
Combines with regular monitoring by a gynecologist or urologist.
Combination
Works together with other treatment methods.
Adaptive cellular immunotherapy
Activated immunocompetent cells are administered directly to the site of chronic inflammation.
Focus diagnostics
Determining the localization and nature of the chronic inflammatory process.
Cell activation
Immunocompetent cells are activated under laboratory conditions for targeted action.
Targeted delivery
Direct administration of activated cells into the chronic inflammation zone.
Relapse control
Restoring local immunity reduces the frequency of exacerbations, even in cases of antibiotic resistance.
Frequently asked questions
How does immunotherapy help with HPV?
The method mobilizes the body's own antiviral immunity to strengthen control over the infection. This helps the body restrain the virus and reduce its activity.
Is HPV dangerous and why bring it under control?
Some types of the virus are linked to a risk of cancer complications, including cervical cancer. That is why it is important to help the body control the infection and continue regular monitoring.
Can the method be combined with other treatments?
Yes. Immunotherapy is combined with other methods and regular monitoring by a gynecologist or urologist. It complements them rather than replacing them.
Does the method cancel screening and monitoring?
No. Screening and follow-up remain essential in HPV, especially in women. Immunotherapy works together with them.
How does the course of treatment go?
After a consultation and assessment of the type of virus and the duration of infection, the physician builds an individual program. The method is gently tolerated.
Can I come for treatment from another region?
Yes. The clinic is near Moscow (Khimki, Skhodnya) and accepts patients from other regions. The first consultation can be held remotely.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.